The Department organised a brain storming session on Post Genome Era in August, 2000. The result has been major projects in the areas microbial genomics, comparative genomics, biocomputing and so on.
A major project on molecular genetic studies of Type-II Diabetes and diabetic retinopathy has been implemented at Madras Diabetes Research Foundation, Chennai
A programme on “Proteomics of Mycobacteria” as one of the components of multi-departmental, multi-investigator project has been initiated at the Indian Institute of Science, Banglaore. Under defined conditions, an unique protein has been identified which appears to have a role in the survival of Mycobacterium tuberculosis in macrophages.
A major effort in the area of pharmacogenomics is being undertaken to develop baseline data for genetic response to important drugs for treatment of rheumatoid arthritis, bipolar cardio-vascular and other diseases by involving major research organizations and hospitals.
As a part of Human Cancer Genome Project – an International Collaborative Initiative (TCGA), International Cancer Genome Consortium (ICGC) programme, the most ambitious biomedical research since Human Genome Project launched was in November, 2008. DBT along with its autonomous institution National Institute of Biomedical Genomics, Kalyani is involved in this project and has already produced high impact research papers.
A major programme on Oral Cancer, most prevalent form of cancer in India, was implemented at the National Institute of Biomedical Genomics (NIBMG), Kalyani, in collaboration with Advanced Centre for Research, Treatment and Education on Cancer (ACTREC), Mumbai.
Under the National Bioethics Committee of Department of Biotechnology, a document on “Ethical Policies for Human Genome Genetic Research and Services” was prepared under the chairmanship of Prof. M.S. Valiathan and widely circulated among scientists and scientific institutions.